BPlex recalled over sterility concerns
- Recall date
- April 8, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Customceutical Compounding recalls BPlex (METHYLCOBALAMIN 1000 MCG/ML PYRIDOXAL 5 PHOSPHATE 20MG/ML DEXPANTHENOL 250MG/ML), 10 ML MULTIDOSE VIAL MDV INJ C…
- Recall number
- D-1253-2019
- FDA classification
- Class II
- Brand / firm
- Customceutical Compounding
- Sold / distributed
- U.S.A. Nationwide
Why it was recalled
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
BPlex (METHYLCOBALAMIN 1000 MCG/ML PYRIDOXAL 5 PHOSPHATE 20MG/ML DEXPANTHENOL 250MG/ML), 10 ML MULTIDOSE VIAL MDV INJ COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272
Get recall alerts
Free email alert whenever Customceutical Compounding has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Customceutical Compounding